RU97114956A - METHOD OF INHIBITING INTER CELL ADHESION AND METHOD OF INHIBITING THE INFLAMMATORY PROCESS - Google Patents

METHOD OF INHIBITING INTER CELL ADHESION AND METHOD OF INHIBITING THE INFLAMMATORY PROCESS

Info

Publication number
RU97114956A
RU97114956A RU97114956/14A RU97114956A RU97114956A RU 97114956 A RU97114956 A RU 97114956A RU 97114956/14 A RU97114956/14 A RU 97114956/14A RU 97114956 A RU97114956 A RU 97114956A RU 97114956 A RU97114956 A RU 97114956A
Authority
RU
Russia
Prior art keywords
inhibiting
hydrochloride
cell adhesion
inflammatory process
specified connection
Prior art date
Application number
RU97114956/14A
Other languages
Russian (ru)
Other versions
RU2179021C2 (en
Inventor
В.Гриннелл Брайан
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/385,934 external-priority patent/US5484808A/en
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of RU97114956A publication Critical patent/RU97114956A/en
Application granted granted Critical
Publication of RU2179021C2 publication Critical patent/RU2179021C2/en

Links

Claims (6)

1. Способ ингибирования межклеточной адгезии, включающий введение нуждающемуся в этом человеку эффективного количества соединения, формулы
Figure 00000001

где R1 и R3 независимо водород, -СН3, -С(O)(С16 алкил), или -С(O)Аr, где Аr - необязательно замещенный фенил;
R2 выбирают из группы, состоящей из пирролидино, гексаметиленимино и пиперидино-групп; или их фармацевтически приемлемых солей и сольватов.
1. A method of inhibiting cell-cell adhesion, comprising administering to an individual in need thereof an effective amount of a compound, a formula
Figure 00000001

where R 1 and R 3 are independently hydrogen, —CH 3 , —C (O) (C 1 -C 6 alkyl), or —C (O) Ar, where Ar is optionally substituted phenyl;
R 2 is selected from the group consisting of pyrrolidino, hexamethyleneimino and piperidino groups; or their pharmaceutically acceptable salts and solvates.
2. Способ по п. 1, в котором указанное соединение представляет собой гидрохлорид. 2. The method according to p. 1, in which the specified connection is a hydrochloride. 3. Способ по п. 2, в котором указанное соединение представляет собой
Figure 00000002

или его гидрохлорид.
3. The method according to p. 2, in which the specified connection is
Figure 00000002

or its hydrochloride.
4. Способ ингибирования воспалительного процесса и процесса нарушенной нормальной коагуляции у пациентов с нарушениями сосудистого эндотелия, включающий введение нуждающемуся в этом пациенту эффективного количества соединения формулы
Figure 00000003

где R1 и R2 независимо водород, -СН3, -С(O)(С16 алкил), или -С(O)Аr, где Аr - необязательно замещенный фенил;
R2 выбирают из группы, состоящей из пирролидино, гексаметиленимино и пиперидино-групп; или их фармацевтически приемлемых солей и сольватов.
4. A method of inhibiting the inflammatory process and the process of impaired normal coagulation in patients with impaired vascular endothelium, comprising administering an effective amount of a compound of the formula
Figure 00000003

where R 1 and R 2 are independently hydrogen, —CH 3 , —C (O) (C 1 -C 6 alkyl), or —C (O) Ar, where Ar is optionally substituted phenyl;
R 2 is selected from the group consisting of pyrrolidino, hexamethyleneimino and piperidino groups; or their pharmaceutically acceptable salts and solvates.
5. Способ по п. 4, в котором указанное соединение представляет собой гидрохлорид. 5. The method according to p. 4, in which the specified connection is a hydrochloride. 6. Способ по п. 4, в котором указанное соединение представляет собой
Figure 00000004

или его гидрохлорид.
6. The method according to p. 4, in which the specified connection is a
Figure 00000004

or its hydrochloride.
RU97114956/14A 1995-02-09 1996-02-09 Method of inhibition of intercellular adhesion and method of inhibition of inflammatory process RU2179021C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/385,934 US5484808A (en) 1995-02-09 1995-02-09 Methods of inhibiting cell-cell adhesion
US08/385,934 1995-02-09

Publications (2)

Publication Number Publication Date
RU97114956A true RU97114956A (en) 1999-07-20
RU2179021C2 RU2179021C2 (en) 2002-02-10

Family

ID=23523494

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97114956/14A RU2179021C2 (en) 1995-02-09 1996-02-09 Method of inhibition of intercellular adhesion and method of inhibition of inflammatory process

Country Status (17)

Country Link
US (2) US5484808A (en)
EP (1) EP0726071A2 (en)
JP (1) JPH10513475A (en)
KR (1) KR19980702079A (en)
CN (1) CN1072931C (en)
AU (1) AU693021B2 (en)
CA (1) CA2212339A1 (en)
CZ (1) CZ286448B6 (en)
HU (1) HUP9801323A3 (en)
IL (1) IL117079A (en)
MY (1) MY132251A (en)
NO (1) NO973635L (en)
NZ (1) NZ305072A (en)
RU (1) RU2179021C2 (en)
UA (1) UA43391C2 (en)
WO (1) WO1996024384A1 (en)
ZA (1) ZA961076B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US5747509A (en) * 1996-06-03 1998-05-05 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US6008232A (en) * 1997-08-20 1999-12-28 Eli Lilly And Company Methods for preventing headaches
WO1999051587A1 (en) * 1998-04-01 1999-10-14 Ono Pharmaceutical Co., Ltd. Fused thiophene derivatives and drugs containing the same as the active ingredient
WO2000066612A1 (en) 1999-05-04 2000-11-09 Strakan Limited Androgen glycosides and androgenic activity thereof
US6359015B1 (en) 2000-02-28 2002-03-19 The United States Of America As Represented By The Department Of Veterans Affairs Method for antagonizing inhibition effects of alcohol on cell adhesion
US20040121313A1 (en) * 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
JP3887588B2 (en) * 2002-08-30 2007-02-28 株式会社リガク Stress measurement method by X-ray diffraction
US6977272B2 (en) * 2002-10-16 2005-12-20 President And Fellows Of Harvard College Method for antagonizing inhibition effects of alcohol on cell adhesion
JP2006516193A (en) * 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド Rapid identification of pathogens in humans and animals
US7964343B2 (en) * 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7956175B2 (en) 2003-09-11 2011-06-07 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US20050266411A1 (en) * 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
AU2006272776B2 (en) * 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
CN107412248A (en) 2016-05-24 2017-12-01 中国医学科学院药物研究所 Application of the THPA in treatment vascular inflammation or improvement function of vascular endothelium

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (en) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 New benzothiophene derivatives
US5356926A (en) * 1992-02-24 1994-10-18 Warner-Lambert Company 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo [β]thiophene-2-carboxamides as inhibitors of cell adhesion
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5457113A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
UA32427C2 (en) * 1993-10-15 2000-12-15 Елі Ліллі Енд Компані The use of benzothiophene or pharmaceutical acceptable salts or solvate thereof for inhibition of angiogenesis and/or angiogenic diseases
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Similar Documents

Publication Publication Date Title
RU97114956A (en) METHOD OF INHIBITING INTER CELL ADHESION AND METHOD OF INHIBITING THE INFLAMMATORY PROCESS
RU97108050A (en) METHOD FOR INHIBITING CONDITIONS ASSOCIATED WITH NEUROPEPTIDE Y
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
DK0651999T3 (en) Methods for inhibiting uterine fibrosis
KR950016725A (en) How to suppress pulmonary hypertension diseases
MX9701325A (en) Methods of inhibiting ulcerative mucositis.
MX9701329A (en) Methods of inhibiting viral replication.
MY112973A (en) Methods for inhibiting vascular smooth muscle cell migration
KR950016723A (en) How to suppress autoimmune diseases
RU98113525A (en) The use of 2-phenyl-3-aroylbenzothiophenes for the inhibition of thrombotic disorder, to increase the activation of protein C
KR950010887A (en) How to inhibit cartilage degeneration
KR950010891A (en) How to treat resistant tumors
NO944926L (en) Methods for Inhibiting Myeloperoxidase Activity
EA199800019A1 (en) METHOD OF INCREASING THE DENSITY OF CALCIUM CHANNELS
RU94013440A (en) DERIVATIVES 3-DEZOXYOLYSACCHARIDES, METHODS OF THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
KR950016734A (en) Inhibition of sexual prematurity
EA199700136A1 (en) METHODS OF INHIBITING EXOGENOUS ESTROGENS
EA199800366A1 (en) METHODS OF INHIBITING INHIBITOR 1 PLASMINOGEN ACTIVATOR
RU97107855A (en) METHOD FOR INHIBITING CONDITIONS ASSOCIATED WITH BRADIKININ
MX9701333A (en) Methods for inhibiting neuronal damage.
EA199800676A1 (en) WAYS TO IMPROVE THE COMPETENCE OF THE SPHINKTER
EA200000243A1 (en) METHODS TO REDUCE THE NUMBER OF PLATELETS
RU97104160A (en) METHOD FOR INHIBITING (CORRECTING) ENDOMETRIAL CANCER
EA199800678A1 (en) METHOD OF INHIBITING MUSCULAR-APONURROTIC FIBROMATOSIS (DEMOID TUMORS)
RU97104094A (en) METHOD FOR PREVENTING BONE DENTURE DEGRADATION